老年男性骨质疏松的危险因素——基于686人的横断面研究
Risk Factors for Osteoporosis in Elderly Men—Based on Across-Sectional Study of 638 Men
DOI: 10.12677/ACM.2023.132228, PDF,   
作者: 刘晓杰, 陈明瑞:青岛大学,山东 青岛;青岛大学附属医院崂山院区脊柱外科,山东 青岛;单 悦, 历建伟, 马学晓*:青岛大学附属医院崂山院区脊柱外科,山东 青岛
关键词: 骨质疏松骨量减少危险因素男性Osteoporosis Osteopenia Risk Factors Male
摘要: 目的:探讨老年男性发生骨质疏松(Osteoporosis, OP)的相关危险因素。方法:回顾性分析2017年1月~2019年12月在我院行骨密度(BMD)检查的686例老年男性的临床资料,并根据BMD T值将其分为3组:骨质正常组,骨量减少组和骨质疏松组,比较3组患者的年龄、BMI、血压、生化指标等情况,分析引起骨量减少以及骨质疏松的危险因素。结果:三组受试者在年龄、BMI和UA水平方面存在显著差异(均P < 0.05),而在舒张压、收缩压、25(OH)D3和HDL-C上差异无统计学意义(均P > 0.05);老年男性BMD T值与年龄和HDL-C (r = -0.143, P < 0.001)呈负相关,而与BMI (r = 0.119, P = 0.002)、舒张压(r = 0.157, P < 0.001)、收缩压(r = 0.142, P < 0.001)、25(OH)D3 (r = 0.083, P < 0.030)和UA (r = 0.133, P < 0.001)呈正相关;年龄(OR = 1.076, 95%CI = 1.046~1.106, P < 0.001)被确定为老年男性OP的独立危险因素,BMI (OR = 0.858, 95%CI = 0.793~0.928, P < 0.001)和UA (OR = 0.995, 95%CI = 0.991~0.998, P = 0.001)则被确定为保护因素。结论:老年男性OP可能与高龄、低BMI以及低UA水平密切相关。
Abstract: Objective: To explore the related risk factors of osteoporosis (OP) in elderly men. Methods: By ana-lyzing the clinical data of 686 elderly men who underwent bone mineral density (BMD) examination in our hospital from January 2017 to December 2019, which were divided into 3 groups according to the BMD T value: normal bone group, osteopenia group and osteoporosis group, we compare the age, BMI, blood pressure, and biochemical indicators of the three groups of patients to analyze the risk factors for osteopenia and osteoporosis. Results: There were significant differences in age, BMI and UA levels among the three groups (all P < 0.05), but no significant differences in diastolic blood pressure, systolic blood pressure, 25(OH)D3 and HDL-C (all P > 0.05). The value of BMD T in elderly men was negatively correlated with age and HDL-C (r = -0.143, P < 0.001), but positively correlated with BMI (r = 0.119, P < 0.001), diastolic blood pressure (r = 0.157, P < 0.001), systolic blood pres-sure (r = 0.142, P < 0.001), 25(OH)D3 (r = 0.083, P < 0.030) and UA (r = 0.133, P < 0.001). Age (OR = 1.076, 95%CI = 1.046~1.106, P < 0.001) was identified as an independent risk factor for OP in older men, BMI (OR = 0.858, 95%CI = 0.793~0.928, P < 0.001) and UA (OR = 0.995, 95%CI = 0.991~0.998, P = 0.001) was determined as a protective factor. Conclusion: OP in older men may be closely relat-ed to advanced age, low BMI, and low UA levels.
文章引用:刘晓杰, 陈明瑞, 单悦, 历建伟, 马学晓. 老年男性骨质疏松的危险因素——基于686人的横断面研究[J]. 临床医学进展, 2023, 13(2): 1652-1657. https://doi.org/10.12677/ACM.2023.132228

参考文献

[1] Lane, J.M., Russell, L. and Khan, S.N. (2000) Osteoporosis. Clinical Orthopaedics and Related Research, 372, 139-150. [Google Scholar] [CrossRef] [PubMed]
[2] Manolagas, S.C. (2010) From Estrogen-Centric to Ag-ing and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis. Endocrine Reviews, 31, 266-300. [Google Scholar] [CrossRef] [PubMed]
[3] Wang, Y., Zhou, R., Zhong, W., et al. (2018) Association of Gout with Osteoporotic Fractures. International Orthopaedics, 42, 2041-2047. [Google Scholar] [CrossRef] [PubMed]
[4] Yan, D.D., Wang, J., Hou, X.H., et al. (2018) Association of Se-rum Uric Acid Levels with Osteoporosis and Bone Turnover Markers in a Chinese Population. Acta Pharmacologica Sinica, 39, 626-632. [Google Scholar] [CrossRef] [PubMed]
[5] Chen, F., Wang, Y., Guo, Y., et al. (2019) Specific Higher Levels of Serum Uric Acid Might Have a Protective Effect on Bone Mineral Density within a Chinese Population over 60 Years Old: A Cross-Sectional Study from Northeast China. Clinical Interventions in Aging, 14, 1065-1073. [Google Scholar] [CrossRef
[6] Zeng, Q., Li, N., Wang, Q., et al. (2019) The Prevalence of Osteoporo-sis in China, a Nationwide, Multicenter DXA Survey. Journal of Bone and Mineral Research, 34, 1789-1797. [Google Scholar] [CrossRef] [PubMed]
[7] Tebé, C., Martínez-Laguna, D., Carbonell-Abella, C., et al. (2019) The As-sociation between Type 2 Diabetes Mellitus, Hip Fracture, and Post-Hip Fracture Mortality: A Multi-State Cohort Analy-sis. Osteoporosis International, 30, 2407-2415. [Google Scholar] [CrossRef] [PubMed]
[8] Medicine, W.J.D. (1999) Definition, Diagnosis and Classifica-tion of Diabetes Mellitus and Its Complications.
[9] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版) [J]. 中华糖尿病杂志, 2014(7): 447-498.
[10] Jordan, K.M. and Cooper, C. (2002) Epidemiology of Osteoporosis. Best Practice & Research: Clinical Rheumatology, 16, 795-806. [Google Scholar] [CrossRef] [PubMed]
[11] Lin, K.M., Lu, C.L., Hung, K.C., et al. (2019) The Paradoxical Role of Uric Acid in Osteoporosis. Nutrients, 11, e31524. [Google Scholar] [CrossRef] [PubMed]
[12] Babaei, M., Shamsi, R., Heidari, B., et al. (2019) Serum Uric Acid Status and Its Association with Bone Mineral Density in the Elderly People Aged 60 Years and More. International Journal of Endocrinology and Metabolism, 17, e80780. [Google Scholar] [CrossRef] [PubMed]
[13] Nabipour, I., Sambrook, P.N., Blyth, F.M., et al. (2011) Serum Uric Acid Is Associated with Bone Health in Older Men: A Cross-Sectional Popula-tion-Based Study. Journal of Bone and Mineral Research, 26, 955-964. [Google Scholar] [CrossRef] [PubMed]
[14] Keizman, D., Ish-Shalom, M., Berliner, S., et al. (2009) Low Uric Acid Lev-els in Serum of Patients with ALS: Further Evidence for Oxidative Stress? Journal of the Neurological Sciences, 285, 95-99. [Google Scholar] [CrossRef] [PubMed]
[15] 王潇丽, 徐丽丽, 杨乃龙. 尿酸对人骨髓间充质干细胞成骨分化过程中Wnt信号通路的影响[J]. 中国组织工程研究, 2015, 19(28): 4472-4477.
[16] Mehta, T., Sarnak, M.J., et al. (2015) Serum Urate Levels and the Risk of Hip Fractures: Data from the Cardiovascular Health Study. Metabolism, 64, 438-446. [Google Scholar] [CrossRef] [PubMed]
[17] Paik, J.M., Kim, S.C., Feskanich, D., et al. (2017) Gout and Risk of Fracture in Women: A Prospective Cohort Study. Arthritis & Rheumatology, 69, 422-428. [Google Scholar] [CrossRef] [PubMed]
[18] Zhao, X., Yu, X. and Zhang, X. (2020) Association between Uric Acid and Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes Mellitus in China: A Cross-Sectional Inpatient Study. Journal of Diabetes Research, 2020, Article ID: 3982831. [Google Scholar] [CrossRef] [PubMed]
[19] Gkastaris, K., Goulis, D.G., Potoupnis, M., et al. (2020) Obesity, Os-teoporosis and Bone Metabolism. The Journal of Musculoskeletal and Neuronal Interactions, 20, 372-381.
[20] Li, G.H., Cheung, C.L., Au, P.C., et al. (2020) Positive Effects of Low LDL-C and Statins on Bone Mineral Density: An Integrated Epidemiological Observation Analysis and Mendelian Randomization Study. International Journal of Epide-miology, 49, 1221-1235. [Google Scholar] [CrossRef] [PubMed]